A Review of Dental Adverse Events Using the FDA Adverse Event Reporting System

被引：0
|
作者：
Altman, Keith [1 ]
Budny, Renata [2 ]
机构：
[1] Law Off Keith Altman, Massapequa Pk, NY USA
[2] New York City Coll Technol, Brooklyn, NY USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
744
引用
收藏
页码：400 / 400
页数：1
相关论文
共 50 条
  • [1] Vedolizumab Adverse Events: Analysis of the FDA Adverse Event Reporting System
    Jow, Steven
    Hutfless, Susan
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S35 - S36
  • [2] Adverse Events of Desvenlafaxine Using FDA Adverse Events Reporting System
    Karydes, H. C.
    Leikin, J. B.
    CLINICAL TOXICOLOGY, 2010, 48 (06) : 664 - 664
  • [3] Evaluating Ubrogepant-related adverse events using the FDA adverse event reporting system
    Cao, Bing
    Gu, Shanshan
    Shen, Zhisen
    Zhang, Yuna
    Shen, Yiming
    Chen, Hang
    EXPERT OPINION ON DRUG SAFETY, 2023, : 297 - 303
  • [4] Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
    Huang, Shulan
    Dong, Hanlin
    Luo, Dongqiang
    Jiang, Jiazhen
    Liu, Manting
    Wu, Jiayu
    Dou, Xiangyun
    Zhou, Siyuan
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [5] Assessing taxane-associated adverse events using the FDA adverse event reporting system database
    Lao, Dong-Hui
    Chen, Ye
    Fan, Jun
    Zhang, Jian-Zhong
    CHINESE MEDICAL JOURNAL, 2021, 134 (12) : 1471 - 1476
  • [6] Comparative Analysis of Psychiatric Adverse Events of Brivaracetam and Levetiracetam Using the FDA Adverse Event Reporting System
    Porwal, Mokshal H.
    Shah, Ipsit
    Shah, Aneri N.
    Obeidat, Ahmed Z.
    ANNALS OF NEUROLOGY, 2022, 92 : S87 - S88
  • [7] Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
    Wen, Ming-Tao
    Li, Jia-Cheng
    Lu, Bo-Wen
    Shao, Hua-Rong
    Ling, Pei-Xue
    Liu, Fei
    Li, Gang
    Luo, Di
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [8] Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database
    Iarikov D.
    Wassel R.
    Farley J.
    Nambiar S.
    Infectious Diseases and Therapy, 2015, 4 (4) : 433 - 458
  • [9] A disproportionality analysis of FDA adverse event reporting system events for misoprostol
    Yang, Li
    Xu, Wenting
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [10] A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab
    Chen, Zepeng
    Li, Ming
    Li, Shuzhen
    Li, Yuxi
    Wu, Junyan
    Qiu, Kaifeng
    Yu, Xiaoxia
    Huang, Lin
    Chen, Guanghui
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (04) : 339 - 342
12345